Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec;98(6):1540-1548.
doi: 10.1016/j.kint.2020.09.006. Epub 2020 Oct 15.

Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe

Kitty J Jager  1 , Anneke Kramer  2 , Nicholas C Chesnaye  2 , Cécile Couchoud  3 , J Emilio Sánchez-Álvarez  4 , Liliana Garneata  5 , Fréderic Collart  6 , Marc H Hemmelder  7 , Patrice Ambühl  8 , Julia Kerschbaum  9 , Camille Legeai  10 , María Dolores Del Pino Y Pino  11 , Gabriel Mircescu  5 , Lionel Mazzoleni  12 , Tiny Hoekstra  7 , Rebecca Winzeler  8 , Gert Mayer  9 , Vianda S Stel  2 , Christoph Wanner  13 , Carmine Zoccali  14 , Ziad A Massy  15
Affiliations

Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe

Kitty J Jager et al. Kidney Int. 2020 Dec.

Abstract

The aim of this study was to investigate 28-day mortality after COVID-19 diagnosis in the European kidney replacement therapy population. In addition, we determined the role of patient characteristics, treatment factors, and country on mortality risk with the use of ERA-EDTA Registry data on patients receiving kidney replacement therapy in Europe from February 1, 2020, to April 30, 2020. Additional data on all patients with a diagnosis of COVID-19 were collected from 7 European countries encompassing 4298 patients. COVID-19-attributable mortality was calculated using propensity score-matched historic control data and after 28 days of follow-up was 20.0% (95% confidence interval 18.7%-21.4%) in 3285 patients receiving dialysis and 19.9% (17.5%-22.5%) in 1013 recipients of a transplant. We identified differences in COVID-19 mortality across countries, and an increased mortality risk in older patients receiving kidney replacement therapy and male patients receiving dialysis. In recipients of kidney transplants ≥75 years of age, 44.3% (35.7%-53.9%) did not survive COVID-19. Mortality risk was 1.28 (1.02-1.60) times higher in transplant recipients compared with matched dialysis patients. Thus, the pandemic has had a substantial effect on mortality in patients receiving kidney replacement therapy, a highly vulnerable population due to underlying chronic kidney disease and a high prevalence of multimorbidity.

Keywords: COVID-19; attributable mortality; dialysis; kidney replacement therapy; registries; transplantation.

PubMed Disclaimer

Figures

None
Graphical abstract
Figure 1
Figure 1
Probability of death among dialysis patients (left panel) and transplant patients (right panel) with coronavirus disease 2019 (COVID-19) and a propensity score–matched control group without COVID-19 (alive at, and followed from, March 15, 2017). CI, confidence interval.
Figure 2
Figure 2
Probability of death 28 days after diagnosis of coronavirus disease 2019 and number at risk for dialysis patients (top) and transplant patients (bottom), by age at diagnosis. Axis scales differ for dialysis and transplant graphs. Two transplant patients >90 years of age at diagnosis were included in the 80+ age group.
Figure 3
Figure 3
Probability of death among dialysis patients (left) and transplant patients (right) with coronavirus disease 2019 (COVID-19), by country. CI, confidence interval.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. European Centre for Disease Prevention and Control COVID-19 situation update for the EU/EEA and the UK. https://www.ecdc.europa.eu/en/cases-2019-ncov-eueea Available at:
    1. Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239–1242. - PubMed
    1. Docherty A.B., Harrison E.M., Green C.A. Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol. medRxiv. 2020;04(23):20076042. - PMC - PubMed
    1. de Jager D.J., Grootendorst D.C., Jager K.J. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA. 2009;302:1782–1789. - PubMed
    1. ERA-EDTA Registry ERA-EDTA Registry Annual Report 2017. 2019. https://www.era-edta.org/en/registry/publications/annual-reports/#2017 Available at:

Publication types

MeSH terms